Talk:Certolizumab pegol

Info on Discovery, Patents, etc.
Would anyone have info on the discovery (who, where, when) of this molecule, as well as what company currently owns its patent? If you have this info, would you please add it to the article so that the reader can trace its history. Thank you. —Preceding unsigned comment added by Tell someone (talk • contribs) 15:51, 25 January 2009 (UTC)

Lack of quality regarding trial evidence
The information regarding trial evidence in Crohn's disease is out of date.

Schreiber S, Lawrance IC, Thomsen OO, Hanauer SB, Bloomfield R, Sandborn WJ. Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study. Alimentary pharmacology & therapeutics 2011;33:185-93.

Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S, Investigators PS. Certolizumab pegol for the treatment of Crohn's disease. New England Journal of Medicine 2007;357:228-38.

Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OO, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ, Investigators PS. Maintenance therapy with certolizumab pegol for Crohn's disease.[Erratum appears in N Engl J Med. 2007 Sep 27;357(13):1357]. New England Journal of Medicine 2007;357:239-50. —Preceding unsigned comment added by 115.70.137.40 (talk) 07:43, 26 March 2011 (UTC)

It is incorrect to call Cimzia a monoclonal antibody
Cimzia (CDP870 development name) is not a monoclonal antibody but rather a Fab fragment of an antibody manufactured in a recombinant microbial culture. — Preceding unsigned comment added by 195.243.132.34 (talk) 07:11, 3 February 2016 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified one external link on Certolizumab pegol. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive https://archive.is/20131001130038/http://www.ucb.presscentre.com/News/Cimzia-certolizumab-pegol-approved-by-the-U-S-FDA-for-treatment-of-adult-patients-with-active-ps-45c.aspx to http://www.ucb.presscentre.com/News/Cimzia-certolizumab-pegol-approved-by-the-U-S-FDA-for-treatment-of-adult-patients-with-active-ps-45c.aspx

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Cheers.— InternetArchiveBot  (Report bug) 08:19, 2 August 2017 (UTC)